Zymenex
Scandinavian biopharmaceutical company focused on the development and commercialization of novel enzyme replacement therapies.
Launch date
Employees
Company register number 27394752
Hillerød Capital Region of Denmark (HQ)
Financials
Estimates*
| EUR | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | - | - | 6.5m | 5.3m | 1.4m |
| % growth | - | - | - | - | - | (19 %) | (73 %) |
| EBITDA | - | - | - | <1m | 45.5m | <1m | <1m |
| % EBITDA margin | - | - | - | - | 695 % | 9 % | 16 % |
| Profit | (5.6m) | (4.5m) | <1m | <1m | 39.2m | <1m | <1m |
| % profit margin | - | - | - | - | 600 % | 9 % | 12 % |
| R&D budget | - | - | - | - | 5.4m | 4.1m | <1m |
| R&D % of revenue | - | - | - | - | 83 % | 78 % | 44 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Acquisition | ||
| Total Funding | - | ||